Hepcidin and Host Defense against Infectious Diseases
Open accessThe DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index; 43 of the 198 sources its claims cite were checked for support.
Abstract
Hepcidin is the master regulator of iron homeostasis in vertebrates. The synthesis of hepcidin is induced by systemic iron levels and by inflammatory stimuli. While the role of hepcidin in iron regulation is well established, its contribution to host defense is emerging as complex and multifaceted. In this review, we summarize the literature on the role of hepcidin as a mediator of antimicrobial immunity. Hepcidin induction during infection causes depletion of extracellular iron, which is thought to be a general defense mechanism against many infections by withholding iron from invading pathogens. Conversely, by promoting iron sequestration in macrophages, hepcidin may be detrimental to cellular defense against certain intracellular infections, although critical in vivo studies are needed to confirm this concept. It is not yet clear whether hepcidin exerts any iron-independent effects on host defenses.
Overview
CoChat Summary
TL;DR
Hepcidin is the master regulator of vertebrate iron homeostasis and is induced by inflammation, but its role in host defense is complex: iron restriction appears protective in some extracellular infections while macrophage iron sequestration may be detrimental in intracellular infections. The review concludes that direct antimicrobial effects of hepcidin in vivo are unlikely and that many roles, especially iron-independent ones, remain speculative.
Key findings
- Hepcidin induction during infection lowers extracellular iron and sequesters iron in macrophages by binding ferroportin and promoting its degradation; this “nutritional immunity” is protective in at least some extracellular bacterial infections, such as *Vibrio vulnificus*, where hepcidin-deficient mice are much more susceptible and hepcidin agonists restore protection.
- In intracellular infections, in vitro data suggest hepcidin-mediated iron accumulation in macrophages may benefit pathogens such as *Salmonella* Typhimurium, *Mycobacterium tuberculosis*, *M. avium*, *Leishmania amazonensis*, *Chlamydia*, and *Legionella*, but in vivo data are conflicting or unaddressed.
- In malaria, hepcidin has complex effects: it likely contributes to anemia but may protect mice by reducing iron availability to parasites; in hepatitis C, HCV suppresses hepcidin expression, contributing to iron overload and disease pathology.
- A direct microbicidal role for hepcidin in mammalian infections is unlikely because serum hepcidin concentrations are 1–2 orders of magnitude lower than those required for antimicrobial effects in vitro. The paper also notes that the common HFE C282Y mutation has a heterozygous prevalence of up to 10% in northern European populations, and that standard mouse chow contains 150–300 ppm iron versus approximately 35 ppm for an iron-sufficient diet.
Methods
- Narrative literature review summarizing published in vitro, animal-model, and human studies on hepcidin in infectious diseases.
- No primary experiments or new data are reported; evidence is synthesized qualitatively and summarized in Table 1 by infection location, pathogen, purported hepcidin role, and quality of evidence.
- The review covers intracellular infections, siderophilic bacterial infections, sepsis, malaria, viral infections including HCV and HIV, and proposed iron-independent functions.
Limitations
- The paper states that critical in vivo studies are needed to confirm whether hepcidin-mediated macrophage iron sequestration is detrimental in intracellular infections, and that any iron-independent role of hepcidin in host defense remains speculative.
- The paper states that the role of hepcidin remains undefined in most infections, with little evidence for a direct microbicidal role in vivo and limited investigation in viral, fungal, and most parasitic infections.
- Evident from the text: this is a narrative review without a systematic search or meta-analysis, and the authors note that in vivo studies are conflicting and that extrapolating from Hfe-deficient mice to hepcidin function is not straightforward because hepcidin expression is only attenuated, not abrogated, in those animals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig 3 Mechanisms of hepcidin induction. In hepatocytes, hepcidin induction is mediated primarily by BMP ligands binding with the HJV/BMPR complex. BMP6 is induced by high iron levels via an undefined mechanism. The protease TMPRSS6 inhibits hepcidin production by degrading HJV in response to low iron levels [95]. High holo-transferrin levels stabilize the transferrin receptor 2 (Tfr2)/HFE complex, which promotes hepcidin induction, possibly by direct binding with HJV or BMPR [100]. Hepcidin can also be induced by IL-6 via STAT3 signaling in hepatocytes and myeloid leukocytes. Inflammation can stimulate hepcidin production in myeloid leukocytes through pathogen recognition receptor signaling and through autocrine and paracrine production of IL-6.](https://figures.cochat.ai/paper-figures/38d70c35d0de4f33badc4443501bd8b8/hepcidin-and-host-defense-against-infectious-diseases-figure-3.jpg)
Verification
Claims the paper makes
10 Valid · 4 Not valid · 42 Not checked · 9 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“This effect has been demonstrated convincingly in vitro”
§ Hepcidin and Host Defense against Infectious Diseases > Conclusions and Areas for Further Study
What the sources say
- Not checked yetcites [32] Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology. 2007; 82(4): 934– 45. 17609338 source
- Not checked yetcites [39] Chlosta S, Fishman DS, Harrington L, Johnson EE, Knutson MD, Wessling-Resnick M, et al The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of Salmonella enterica. Infection and Immunity. 2006; 74(5): 3065– 7. 16622252 PMC1459754 source
- Partly supportedcites [40] Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, Lindner E, et al Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009; 114: 3642– 51. 10.1182/blood-2009-05-223354 19700664 PMC2766679 sourceExperimental — accuracy not yet measured
The Discussion reports that synthetic Hamp (hepcidin) reduced iron release from Salmonella-infected macrophages in vitro. It does not report that hepcidin worsened the infection or increased bacterial survival; the in-vitro infection findings instead concern Hfe deficiency and lipocalin-2. Thus the proposed detrimental effect is not demonstrated by the hepcidin experiment. (LLM, conf=0.83)
- Not checked yetcites [41] Kim D-K, Jeong J-H, Lee J-M, Kim KS, Park S-H, Kim YD, et al Inverse agonist of estrogen-related receptor [gamma] controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014; 20(4): 419– 24. 10.1038/nm.3483 24658075 source
- Disputedcites [42] Yuki KE, Eva MM, Richer E, Chung D, Paquet Mn, Cellier M, et al Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant. PloS one. 2013; 8(2): e55331 10.1371/journal.pone.0055331 23390527 PMC3563626 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) describes a possible antimicrobial effect of hepcidin on bacterial growth observed in vitro, not a detrimental effect of hepcidin in intracellular infections. It also reports that hepcidin treatment improved resistance to Salmonella infection in heterozygous mice. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [43] Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, Cherayil BJ. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. The Journal of Immunology. 2008; 181(4): 2723– 31. 18684963 PMC2561261 sourceExperimental — accuracy not yet measured
The Introduction reports cell-culture studies in which increased macrophage ferroportin, associated with low hepcidin, inhibited intracellular pathogen growth. But this paper did not directly test hepcidin's effect on infection in vitro; its Results and Discussion describe only a modest reduction in Salmonella growth in Hfe-deficient macrophages. Calling hepcidin's detrimental effect convincingly demonstrated by this paper overstates its evidence. (LLM, conf=0.86)
- Not checked yetcites [49] Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. Journal of Leukocyte Biology. 2007; 81(1): 195– 204. 17038583 source
- Could not verifycites [50] Olakanmi O, Schlesinger LS, Ahmed A, Britigan BE. Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools: IMPACT OF INTERFERON-γ AND HEMOCHROMATOSIS. Journal of Biological Chemistry. 2002; 277(51): 49727– 34. 12399453 sourceExperimental — accuracy not yet measured
The Results report reduced iron acquisition by intracellular M. tuberculosis in macrophages from patients with hemochromatosis, but do not test hepcidin. The Discussion says the effect of that phenotype on intracellular pathogen growth had not yet been studied. A search for hepcidin found no passage demonstrating its detrimental effect in vitro. (LLM, conf=0.76)
- Partly supportedcites [51] Gomes-Pereira S, Rodrigues PN, Appelberg R, Gomes MS. Increased Susceptibility to Mycobacterium avium in Hemochromatosis Protein HFE-Deficient Mice. Infection and Immunity. 2008; 76(10): 4713– 9. 10.1128/IAI.00612-08 18694968 PMC2546818 sourceExperimental — accuracy not yet measured
The Discussion suggests that iron redistribution thought to result from hepcidin production may promote mycobacterial growth in previously iron-overloaded animals. It does not demonstrate a detrimental effect of hepcidin in vitro; the authors report no difference in M. avium growth between HFE-deficient and control mouse macrophages in vitro. Our copy provides no page numbers for these passages. (LLM, conf=0.86)
- Not checked yetcites [52] Johnson EE, Sandgren A, Cherayil BJ, Murray M, Wessling-Resnick M. Role of Ferroportin in Macrophage-Mediated Immunity. Infection and Immunity. 2010; 78(12): 5099– 106. 10.1128/IAI.00498-10 20837712 PMC2981308 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“may be detrimental in defense against pathogens that occupy this intracellular niche”
- Also stated in: § Conclusions and Areas for Further Study · hedged
“potentially detrimental in host defense against pathogens that reside in the intracellular compartment”
§ Hepcidin and Host Defense against Infectious Diseases > Conclusions and Areas for Further Study
What the sources say
- Not checked yetcites [32] Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology. 2007; 82(4): 934– 45. 17609338 source
- Not checked yetcites [39] Chlosta S, Fishman DS, Harrington L, Johnson EE, Knutson MD, Wessling-Resnick M, et al The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of Salmonella enterica. Infection and Immunity. 2006; 74(5): 3065– 7. 16622252 PMC1459754 source
- Partly supportedcites [40] Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, Lindner E, et al Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009; 114: 3642– 51. 10.1182/blood-2009-05-223354 19700664 PMC2766679 sourceExperimental — accuracy not yet measured
The Introduction (PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS > Introduction) does establish the mechanistic premise: the acute-phase reactant Hamp (hepcidin) binds Fpn1, causing its internalization and proteolysis with 'subsequent blockade of iron export', and the same section frames intracellular infection as a contest over iron ('host phagocytes and invading pathogens have a shared requirement for iron... a central battlefield that determines the course of disease'). But our copy nowhere states or concludes that hepcidin may be detrimental to host defense against intracellular pathogens; the paper's own argument runs the other way mechanistically, attributing the Hfe-deficiency phenotype to Lcn2 rather than to hepcidin — the Results ('Iron homeostasis, immune response, and peripheral blood count...') report that Hamp mRNA levels were not significantly different between infected WT and Hfe-deficient animals, and the Discussion states that differences in iron export are 'not primarily due to differential expression of Fpn1'. So the 'detrimental in defense against pathogens occupying this intracellular niche' part of the claim is not supported by this source, and the hepcidin-specific conclusion is an extrapolation (the paper does cite others' work on hepcidin, e.g. refs 14, 16, 17, 35, without drawing that inference). (LLM, conf=0.65)
- Not checked yetcites [41] Kim D-K, Jeong J-H, Lee J-M, Kim KS, Park S-H, Kim YD, et al Inverse agonist of estrogen-related receptor [gamma] controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014; 20(4): 419– 24. 10.1038/nm.3483 24658075 source
- Disputedcites [42] Yuki KE, Eva MM, Richer E, Chung D, Paquet Mn, Cellier M, et al Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant. PloS one. 2013; 8(2): e55331 10.1371/journal.pone.0055331 23390527 PMC3563626 sourceExperimental — accuracy not yet measured
Our copy of Yuki et al. (2013) argues the opposite for an intracellular pathogen: the Discussion states that Hamp-deficient mice 'are highly susceptible to Salmonella infection' and that hepcidin treatment 'was clearly beneficial in Ank1+/Ity16 heterozygous mice', with low Hamp contributing to iron accumulation that 'favor[s] bacterial growth' (Discussion). The paper also raises a possible direct antimicrobial effect of hepcidin (Discussion, citing [56]), while noting that effect has been shown only in vitro. No passage in our copy presents hepcidin as detrimental to defense against intracellular pathogens; the closest contrary statements are those above. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [43] Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, Cherayil BJ. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. The Journal of Immunology. 2008; 181(4): 2723– 31. 18684963 PMC2561261 sourceExperimental — accuracy not yet measured
Our copy supplies the mechanistic basis for the claim but not the claim itself: the INTRODUCTION states hepcidin binds ferroportin on macrophages and induces its degradation, interrupting iron export, and that elevated FPN/low intracellular iron inhibits growth of Salmonella and other intra-macrophage pathogens — but that protective idea is presented as a suggestion credited to Moalem et al. 2004 (ref 27) and to cell-culture studies (refs 28-31), framed around hemochromatosis/FPN rather than hepcidin being detrimental. The paper never states that hepcidin impairs defense against intracellular pathogens; its own DISCUSSION points the other way, noting that Hfe deficiency (low hepcidin, high FPN) enhanced Salmonella recovery from tissues in vivo because of the attenuated inflammatory response. So the hepcidin-as-detrimental conclusion attributed here is not supported by this source. (LLM, conf=0.66)
- Not checked yetcites [49] Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. Journal of Leukocyte Biology. 2007; 81(1): 195– 204. 17038583 source
- Could not verifycites [50] Olakanmi O, Schlesinger LS, Ahmed A, Britigan BE. Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools: IMPACT OF INTERFERON-γ AND HEMOCHROMATOSIS. Journal of Biological Chemistry. 2002; 277(51): 49727– 34. 12399453 sourceExperimental — accuracy not yet measured
Our copy of Olakanmi et al. (2002) never mentions hepcidin (searched: hepcidin, ferroportin, iron export, host defense/intracellular niche); the paper's scope is intraphagosomal M. tuberculosis iron acquisition from extracellular transferrin versus endogenous macrophage pools, and how IFN-gamma and the hereditary hemochromatosis HFE phenotype alter it. The closest content — Abstract/Discussion statements that 'access to internal macrophage iron pools may be critical for the replication of intraphagosomal M. tuberculosis' and that low macrophage intracellular iron in hemochromatosis 'could limit M. tuberculosis growth' — supports the general premise about intracellular iron pools but attributes nothing to hepcidin, so the claim as stated cannot be checked against this source. (LLM, conf=0.70)
- Partly supportedcites [51] Gomes-Pereira S, Rodrigues PN, Appelberg R, Gomes MS. Increased Susceptibility to Mycobacterium avium in Hemochromatosis Protein HFE-Deficient Mice. Infection and Immunity. 2008; 76(10): 4713– 9. 10.1128/IAI.00612-08 18694968 PMC2546818 sourceExperimental — accuracy not yet measured
The DISCUSSION passage does link hepcidin to a potentially harmful outcome for defense against intracellular (macrophage-dwelling) mycobacteria: it describes the IL-6-induced hepcidin production / iron-withholding alterations and then states that, in mycobacterial infection, 'these same alterations seem to promote the growth of the pathogen.' However, the source attaches a decisive qualifier — this detrimental effect is asserted only 'in the case of mycobacterial infection in the context of a previously iron-overloaded animal' (Hfe−/− and β2m−/− mice), whereas in ordinary circumstances the same hepcidin-driven changes are said to be 'presumed to contribute to host protection.' The claim drops the iron-overload condition and generalizes from mycobacteria to 'pathogens that occupy the intracellular niche,' which the paper does not support; the hepcidin mechanism itself is credited to Ganz 2006 (ref. 10) rather than demonstrated in this work. (LLM, conf=0.75)
- Not checked yetcites [52] Johnson EE, Sandgren A, Cherayil BJ, Murray M, Wessling-Resnick M. Role of Ferroportin in Macrophage-Mediated Immunity. Infection and Immunity. 2010; 78(12): 5099– 106. 10.1128/IAI.00498-10 20837712 PMC2981308 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusions and Areas for Further Study · hedged
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Detrimental, by promoting sequestration of iron in macrophages”
§ Hepcidin and Host Defense against Infectious Diseases > Conclusions and Areas for Further Study
What the sources say
- Not checked yetcites [32] Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology. 2007; 82(4): 934– 45. 17609338 source
- Not checked yetcites [39] Chlosta S, Fishman DS, Harrington L, Johnson EE, Knutson MD, Wessling-Resnick M, et al The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of Salmonella enterica. Infection and Immunity. 2006; 74(5): 3065– 7. 16622252 PMC1459754 source
- Partly supportedcites [40] Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, Lindner E, et al Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009; 114: 3642– 51. 10.1182/blood-2009-05-223354 19700664 PMC2766679 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says hepcidin blocks macrophage iron export, and the Discussion (page unavailable) reports that exporting iron from infected macrophages helps restrict S. Typhimurium. This supports the proposed mechanism, but the paper does not show that hepcidin worsens infection; it discusses M. tuberculosis in relation to iron withholding and provides no corresponding finding for M. avium. (LLM, conf=0.84)
- Not checked yetcites [41] Kim D-K, Jeong J-H, Lee J-M, Kim KS, Park S-H, Kim YD, et al Inverse agonist of estrogen-related receptor [gamma] controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014; 20(4): 419– 24. 10.1038/nm.3483 24658075 source
- Disputedcites [42] Yuki KE, Eva MM, Richer E, Chung D, Paquet Mn, Cellier M, et al Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant. PloS one. 2013; 8(2): e55331 10.1371/journal.pone.0055331 23390527 PMC3563626 sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports that hepcidin treatment improved resistance to Salmonella infection in Ank1+/Ity16 mice, contrary to the claim that hepcidin is detrimental in S. Typhimurium infection. The paper does not establish the proposed macrophage iron-sequestration mechanism or address M. avium. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [43] Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, Cherayil BJ. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. The Journal of Immunology. 2008; 181(4): 2723– 31. 18684963 PMC2561261 sourceExperimental — accuracy not yet measured
The Introduction states that hepcidin blocks iron export from macrophages and that lowering intracellular iron can inhibit S. Typhimurium and other intracellular pathogens. But the paper does not specifically address M. avium, and its Discussion reports that mice with low hepcidin and increased macrophage iron export had a higher Salmonella burden in vivo. It therefore does not support an unqualified claim that hepcidin is detrimental across the listed infections. (LLM, conf=0.86)
- Not checked yetcites [49] Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. Journal of Leukocyte Biology. 2007; 81(1): 195– 204. 17038583 source
- Partly supportedcites [50] Olakanmi O, Schlesinger LS, Ahmed A, Britigan BE. Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools: IMPACT OF INTERFERON-γ AND HEMOCHROMATOSIS. Journal of Biological Chemistry. 2002; 277(51): 49727– 34. 12399453 sourceExperimental — accuracy not yet measured
The Results and Discussion (pages unavailable) show that intraphagosomal M. tuberculosis acquires iron from macrophage pools and has less access to iron in macrophages from patients with hemochromatosis. This supports the iron-availability rationale for M. tuberculosis, but the paper does not establish that hepcidin promotes iron sequestration or is detrimental during infection, and it does not address S. Typhimurium or M. avium. (LLM, conf=0.78)
- Partly supportedcites [51] Gomes-Pereira S, Rodrigues PN, Appelberg R, Gomes MS. Increased Susceptibility to Mycobacterium avium in Hemochromatosis Protein HFE-Deficient Mice. Infection and Immunity. 2008; 76(10): 4713– 9. 10.1128/IAI.00612-08 18694968 PMC2546818 sourceExperimental — accuracy not yet measured
The Discussion describes iron accumulating in granuloma macrophages during M. avium infection and suggests that hepcidin-related reductions in iron release may promote pathogen growth in previously iron-overloaded mice. It does not establish that hepcidin is detrimental in intramacrophage infections generally, or for S. Typhimurium and M. tuberculosis specifically. (LLM, conf=0.87)
- Not checked yetcites [52] Johnson EE, Sandgren A, Cherayil BJ, Murray M, Wessling-Resnick M. Role of Ferroportin in Macrophage-Mediated Immunity. Infection and Immunity. 2010; 78(12): 5099– 106. 10.1128/IAI.00498-10 20837712 PMC2981308 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The study of hepcidin regulation in mice housed under standard conditions is confounded by the high iron content of most commercial mouse chow blends.”
§ Hepcidin and Host Defense against Infectious Diseases > Introduction > Hepcidin, inflammation, and the regulation of systemic iron availability
What the sources say
- Supportedcites [16] Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation. 2004; 113(9): 1271– 6. 15124018 PMC398432 source
The Methods 'Animals' section states that all mice were kept on commercial chows with 336 mg iron/kg (NIH 31) or 440 mg/kg (Prolab RMH 2000), and that in pilot studies hepatic hepcidin mRNA was high and not inducible by LPS, parenteral iron, or turpentine on such a high-iron diet (against an estimated minimal daily requirement of 35 mg/kg), forcing the authors to switch mice to a 2-4 ppm iron diet 12-15 days before experiments. That is precisely the confound the citing sentence attributes: standard housing/chow raises hepcidin and blunts its regulation. The only element not literally stated is the quantifier 'most' commercial blends — the paper documents two named standard chows rather than surveying chows generally. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Multiple lines of evidence suggest that this battle for iron is a critical component of antimicrobial defenses in many infections [3].”
§ Hepcidin and Host Defense against Infectious Diseases > Introduction
What the sources say
- Supportedcites [3] Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS pathogens. 2013; 6(8): e1000949. PMC2920840 20711357 source
The ‘Vertebrates Sequester Iron from Invading Pathogens’ section calls iron sequestration a major form of nutritional immunity and describes increased susceptibility to infection when iron overload weakens that defense. The ‘Targeting Bacterial Iron Acquisition as a Second Layer of Defense against Infection’ section describes an additional host defense against bacterial iron uptake. Together, these passages support the claim across multiple bacterial infections. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
41 more claims · 7 with their cited sources checked
Create a free account to see all 65 claims and to verify the 155 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, hepcidin appears to protect the host against malaria but to promote the growth of pathogens that reside within the intracellular niche of macrophages (10).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [10]
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 1×
“Hepcidin limits the pool of extracellular iron by binding ferroportin and mediating its degradation, thus preventing iron release from intracellular sources (Fig 2) [9].”
BackgroundSelf-citationThe interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Sustained elevation of hepcidin expression, as occurs in many inflammatory states, results in anemia due to reduced availability of iron for erythropoiesis, a condition previously known as “anemia of chronic disease” and more accurately renamed as “anemia of inflammation” [16,22,23].”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 2×
“Hepcidin was first described as a cationic antimicrobial peptide with microbicidal properties against many microorganisms in vitro [5,7].”
BackgroundSelf-citationHentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“The peptide hepcidin is the master regulator of iron homeostasis in vertebrates [4–6].”
BackgroundIron Metabolism in Pathogenic Bacteria
Ratledge, C., & Dover, L. G. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.881 · Cited by 1,539 · cited 1×
“Conversely, professional pathogens have evolved strategies to scavenge iron from the iron-binding proteins of the hosts [2].”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“Hepcidin is strongly induced during inflammation [8], and emerging data support its role in the pathogenesis of a number of infections.”
BackgroundSelf-citationLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 2×
“Hepcidin was first described as a cationic antimicrobial peptide with microbicidal properties against many microorganisms in vitro [5,7].”
BackgroundNicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233 · cited 1×
“In contrast, inability to produce or respond to hepcidin causes hereditary hemochromatosis, a group of iron overload disorders resulting from excessive dietary iron absorption and inability to sequester iron in macrophages [4].”
Background
Cited by
Siderophores in Iron Metabolism: From Mechanism to Therapy Potential
Wilson, B. R., Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.10.005 · Cited by 477
“Hepcidin, a mammalian peptide hormone mainly produced in the liver and in macrophages, binds to Fpn and induces Fpn degradation, decreasing iron export activity and conserving intracellular iron stores on target cells [34].”
BackgroundRegulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Self-citationLiver macrophages in health and disease
Guilliams, M., & Scott, C. L. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.002 · Cited by 395
Alcayaga-Miranda, F., Cuenca, J., & Khoury, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00339 · Cited by 296
“An hepcidin-mediated hypoferremia could functions as a host defense mechanism that evolved to restrict iron availability and slow the pathogen growth (70, 71).”
BackgroundHuman Antimicrobial Peptides as Therapeutics for Viral Infections
Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., & Narayanan, A. (2019) · Viruses · doi:10.3390/v11080704 · Cited by 220
“Consequently, high levels of hepcidin result in inhibition of iron uptake and sequestration of blood iron in macrophages, whereas low levels of hepcidin result in excessive uptake and toxic accumulation of dietary iron [137, 138] .”
Background
Metadata
- Authors
- Michels, K., Nemeth, E., Ganz, T., & Mehrad, B.
- Affiliations
- University of Virginia (US)
- University of California, Los Angeles (US)
- Corresponding author
- Mehrad, Borna
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-20
- Volume
- 11
- Issue
- 8
- Pages
- e1004998
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4546197
- OpenAlex
- W1141274631
- Semantic Scholar
- fc4fbff3cd98ffbf0a1bf3e44b4118da502d023d
- Cited by
- 205
- References
- 103
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 13 · 2023: 16 · 2022: 21 · 2021: 28 · 2020: 23 · 2019: 20 · 2018: 27 · 2017: 23 · 2016: 14 · 2015: 1
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL098526, HL098526, R01HL098329, HL098329)
- National Institute of Allergy and Infectious Diseases (AI117397, R21AI117397, T32AI007046)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090554, R01DK107309, DK090554)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hepcidin, iron homeostasis, host defense, antimicrobial immunity, iron sequestration, macrophages, intracellular infection, inflammation, iron depletion, infectious diseases
- MeSH terms
- Animals, Communicable Diseases, Humans, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepcidin and Host Defense against Infectious Diseases. https://app.cochat.ai/papers/10.1371/journal.ppat.1004998
- The paper
- Michels, K., Nemeth, E., Ganz, T., & Mehrad, B. (2015). Hepcidin and Host Defense against Infectious Diseases. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1004998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.